BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3922319)

  • 1. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
    Gentile JM; Brown S; Aardema M; Clark D; Blankespoor H
    Arch Environ Health; 1985; 40(1):5-12. PubMed ID: 3922319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxidative activation of 3,3'-dichlorobenzidine to mutagenic products in the Salmonella typhimurium test.
    Lang B; Iba MM
    Mutat Res; 1987; 191(3-4):139-43. PubMed ID: 3306365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.
    Ghosal A; Iba MM
    Mutat Res; 1992 Jan; 278(1):31-41. PubMed ID: 1370117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver.
    Matsuoka H; Aji T; Ishii A; Arimoto S; Wataya Y; Hayatsu H
    Mutat Res; 1989 Nov; 227(3):153-7. PubMed ID: 2509904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
    El-Torkey NM; Weisburger EK
    Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
    Johnson TE; Umbenhauer DR; Galloway SM
    Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
    Hyde R; Smith JN; Ioannides C
    Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic activation of carcinogens in human, rat, and hamster hepatocytes.
    Synder S; Hsu IC; Trump BF
    Mutat Res; 1987 Feb; 182(1):31-9. PubMed ID: 3100948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in mutagen activation by rat tissues.
    Robertson IG; Birnbaum LS
    Chem Biol Interact; 1982 Jan; 38(2):243-52. PubMed ID: 6799214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of storage at 4 degrees on prepared Salmonella/microsome test plates.
    Stanton CA; Riley SE; Garner RC
    Mutat Res; 1984 Sep; 141(1):7-9. PubMed ID: 6482897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-naphthoflavone on the metabolism of aflatoxin B1 in hamsters.
    Santhanam K; Lotlikar PD
    Cancer Lett; 1989 May; 45(2):129-34. PubMed ID: 2499415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 3,3'-dichlorobenzidine to DNA and polyribonucleotides in vitro.
    Bratcher SC; Sikka HC
    Chem Biol Interact; 1982 Feb; 38(3):369-75. PubMed ID: 7060216
    [No Abstract]   [Full Text] [Related]  

  • 14. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM; DeRuiter E
    Toxicol Lett; 1981; 8(4-5):273-82. PubMed ID: 6791314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure.
    Doolittle DJ; Lee DA; Rahn CA
    Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 3,3'-dichlorobenzidine: enzymic basis and toxicological consequences.
    Iba MM
    Drug Metab Rev; 1989-1990; 21(3):377-400. PubMed ID: 2701169
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.
    Faletto MB; Gurtoo HL
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):252-62. PubMed ID: 2496488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of microsome-mediated aflatoxin B1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferases in rat and hamster livers.
    Lotlikar PD; Jhee EC; Insetta SM; Clearfield MS
    Carcinogenesis; 1984 Feb; 5(2):269-76. PubMed ID: 6421504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promutagen activation in partially hepatectomized mice.
    Vandewaa EA; Barney CC; Gentile JM
    Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.